Home › Funds › Employees Provident Fund Board › BIIB
Employees Provident Fund Board position in BIIB
BIOGEN INC · Health Care
Employees Provident Fund Board reported holding 783,024 shares of BIIB (BIOGEN INC) in its Q3 2026 13F filing — a position valued at US$176.9M, representing 0.92% of its reported portfolio and ranking #32 among its reported holdings. Employees Provident Fund Board has disclosed BIIB holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Employees Provident Fund Board's BIIB position evolved
Employees Provident Fund Board first disclosed a stake in BIIB in Q3 2023 at 442,416 shares (US$113.7M). The position peaked in Q3 2026 at 783,024 shares, worth US$176.9M. Across 13 filings, Employees Provident Fund Board increased the stake 4 time(s), trimmed it 0 time(s) and left it unchanged 8 time(s). The most recent filing (Q3 2026) shows 783,024 shares valued at US$176.9M — an increase of 78,828 shares quarter over quarter.. Notable position changes include a 28% increase in Q4 2023 (shares fell 17% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 442.42K | $113.71M | New |
| Q4 2023 | 564.27K | $146.02M | Add |
| Q1 2024 | 678.08K | $146.21M | Add |
| Q2 2024 | 678.08K | $157.19M | Hold |
| Q3 2024 | 678.08K | $131.44M | Hold |
| Q4 2024 | 704.20K | $107.69M | Add |
| Q1 2025 | 704.20K | $96.36M | Hold |
| Q2 2025 | 704.20K | $88.44M | Hold |
| Q3 2025 | 704.20K | $98.64M | Hold |
| Q4 2025 | 704.20K | $123.93M | Hold |
| Q1 2026 | 704.20K | $129.10M | Hold |
| Q2 2026 | 704.20K | $152.15M | Hold |
| Q3 2026 | 783.02K | $176.87M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BIIB and 13F data
BIIB (BIOGEN INC) is a Health Care company. 20 other funds we track also report a position in BIIB — the largest reported positions include PRIMECAP MANAGEMENT CO/CA/ (US$3.43B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BIIB
- PRIMECAP MANAGEMENT CO/CA/ 15.20M sh · $3.43B · Q3 2026
More on Employees Provident Fund Board
FAQ
How long has Employees Provident Fund Board held BIIB?
Employees Provident Fund Board has disclosed BIIB holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Employees Provident Fund Board's current position in BIIB?
As of Q3 2026, Employees Provident Fund Board holds 783.02K shares of BIIB (BIOGEN INC), valued at $176.87M, representing 0.92% of its reported portfolio and ranking #32.
Has Employees Provident Fund Board been buying or selling BIIB?
In the latest 13F filing (Q3 2026), Employees Provident Fund Board increased its position in BIIB. The position peaked in Q3 2026 at 783.02K shares.
Which other funds hold BIIB?
Other major institutional holders of BIIB include PRIMECAP MANAGEMENT CO/CA/, among 20 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.